Stay updated on Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.

Latest updates to the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows a 403 Forbidden error instead of study details. This indicates the study record is currently inaccessible on ClinicalTrials.gov.SummaryDifference18%

- Check23 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0 to reflect a newer version of the study record.SummaryDifference0.0%

- Check30 days agoChange DetectedA new bibliographic entry was added to the Publications section, citing Moehler et al., 'Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With Tislelizumab' (Mod Pathol, 2025).SummaryDifference0.0%

- Check44 days agoChange DetectedA new funding/identifier entry, '2017 ( U.S. NIH Grant/Contract )', was added to the study IDs, and the site footer revision updated to 'Revision: v3.6.6'.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new version of the study page.SummaryDifference0.0%

Stay in the know with updates to Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Chemotherapy in Esophageal Cancer Clinical Trial page.